Vanda Pharmaceuticals
VNDA
#7204
Rank
โ‚น44.70 B
Marketcap
โ‚น756.31
Share price
4.72%
Change (1 day)
83.48%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚น10.47 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.21 Billion. In 2024 the company made an earning of -โ‚น3.75 Billion a decrease over its 2023 earnings that were of -โ‚น1.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น10.47 Billion179.47%
2024 -โ‚น3.75 Billion191.43%
2023 -โ‚น1.29 Billion-320.45%
2022 โ‚น0.58 B-84.99%
2021 โ‚น3.88 B54.8%
2020 โ‚น2.50 B19.42%
2019 โ‚น2.10 B4.93%
2018 โ‚น2.00 B-228.6%
2017 -โ‚น1.56 Billion-8.98%
2016 -โ‚น1.72 Billion-53.79%
2015 -โ‚น3.71 Billion-30.18%
2014 -โ‚น5.31 Billion173.08%
2013 -โ‚น1.95 Billion-25.33%
2012 -โ‚น2.61 Billion163.61%
2011 -โ‚น0.99 Billion-221.15%
2010 โ‚น0.81 B-124.53%
2009 -โ‚น3.32 Billion-29.44%
2008 -โ‚น4.71 Billion-36.2%
2007 -โ‚น7.38 Billion21.81%
2006 -โ‚น6.06 Billion170.55%
2005 -โ‚น2.24 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.984 T-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.506 T-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น1.091 T-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.073 T-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.127 T-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น739.99 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚น0.26 Billion-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA